Ilan Pacholder - Elbit Systems President
| ESLT Stock | ILA 90,020 2,680 2.89% |
President
Mr. Ilan Pacholder serves as Executive Vice President Mergers and Acquisitions and Financing at Elbit Systems Ltd since August 2009. His work experience at the Company includes the following roles Executive Vice President Mergers and Acquisitions, Financing and offset, Executive Vice President Financing and offset, Corporationrationrate Vice President offset, Corporationrationrate Secretary and Vice President Finance and Capital Markets and Vice President Finance . His career also includes the following roles Vice President and Chief Financial Officer at Tadiran Communications Ltd, Chief Financial Officer at Sanyo Industries and Vice President in the international and domestic lending departments at Bank Leumi . He holds a Bachelors degree in Accounting and Economics from City University of New York at Queens College and a MBA degree, majoring in Finance and Investments, from Adelphi University. since 2015.
| Age | 64 |
| Tenure | 9 years |
| Professional Marks | MBA |
| Phone | (972) 4 8316659 |
| Web | www.elbitsystems.com |
Elbit Systems Management Efficiency
The company has return on total asset (ROA) of 0.0218 % which means that it generated a profit of $0.0218 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.0778 %, meaning that it generated $0.0778 on every $100 dollars invested by stockholders. Elbit Systems' management efficiency ratios could be used to measure how well Elbit Systems manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | PRESIDENT Age | ||
| Ofer Levy | Bank Hapoalim | 65 | |
| Eran Liron | Nice | 51 | |
| Gianfranco Nazzi | Teva Pharmaceutical Industries | 50 | |
| Yaron Hertz | Nice | N/A | |
| John OHara | Nice | 65 | |
| Christopher Wooten | Nice | 57 | |
| Kevin Mannix | Teva Pharmaceutical Industries | N/A | |
| Sven Dethlefs | Teva Pharmaceutical Industries | 54 | |
| Golan Scherman | Bank Hapoalim | 51 | |
| Amir Nachlieli | Bezeq Israeli Telecommunication | 56 | |
| Tsahi Cohen | Bank Hapoalim | 53 | |
| Richard Daniell | Teva Pharmaceutical Industries | 52 | |
| Eti BenZeev | Bank Hapoalim | 56 | |
| Eliyahu Kalif | Teva Pharmaceutical Industries | 50 | |
| Tali MirskyLachman | Nice | 51 | |
| David Stark | Teva Pharmaceutical Industries | 54 | |
| Yael Almog | Bank Hapoalim | 55 | |
| Ronen Stein | Bank Hapoalim | 51 | |
| Yael Dromi | Bank Hapoalim | 45 | |
| Brendan OGrady | Teva Pharmaceutical Industries | 52 | |
| Ofer Koren | Bank Hapoalim | 47 | |
Management Performance
| Return On Equity | 0.0778 | |||
| Return On Asset | 0.0218 |
Elbit Systems Leadership Team
Elected by the shareholders, the Elbit Systems' board of directors comprises two types of representatives: Elbit Systems inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Elbit. The board's role is to monitor Elbit Systems' management team and ensure that shareholders' interests are well served. Elbit Systems' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Elbit Systems' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Bilha Shapira, Director | ||
| David Temin, Executive Vice President, Chief Compliance Officer and Senior Counsel | ||
| Raanan Horowitz, President & Chief Executive Officer of Elbit Systems of America (a subsidiary) | ||
| Dov Ninveh, Director | ||
| Rami Myerson, Director Relations | ||
| Yaacov Kagan, Ex CFO | ||
| Rina Baum, Director | ||
| Edgar Maimon, Executive Vice President and General Manager - EW and SIGINT Elisra Division | ||
| Ran Kril, Executive Vice President - International Marketing and Business Development | ||
| Zeev Gofer, Executive Vice President – Strategic and Business Development - North America | ||
| Michael Federmann, Chairman of the Board | ||
| Yehoshua Gleitman, External (Independent) Director | ||
| Jonathan Ariel, Executive Vice President & Chief Legal Officer | ||
| Yehoshua Yehuda, Executive Vice President-Chief Technology Officer | ||
| Joseph Gaspar, CFO, Principal Accounting Officer and Executive VP | ||
| Yoram BenZeev, Independent Director | ||
| Shelly Gordon, Executive Vice President of Human Resources | ||
| Yoram Shmuely, Executive Vice President and Co-General Manager - Aerospace Division | ||
| Ilan Pacholder, Executive Vice President - Mergers and Acquisitions, Offset and Financing | ||
| Yuli Tamir, Independent Director | ||
| Ehood Nisan, Independent Director | ||
| Yehuda Vered, Executive Vice President and General Manager – Land and C4I Division | ||
| Bezhalel Machlis, President, Chief Executive Officer | ||
| Elad Aharonson, Executive Vice President and General Manager - Unmanned Aircraft System (UAS) Division | ||
| David Federmann, Vice Chairman of the Board | ||
| Haim Delmar, Executive Vice President and General Manager - C4I and Cyber Division | ||
| Avi Mizrachi, Executive Vice President-Business Development-Israel & Southeast Asia | ||
| Yuval Ramon, Chief Operating Officer, Executive Vice President |
Elbit Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Elbit Systems a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.0778 | |||
| Return On Asset | 0.0218 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 29.61 B | |||
| Shares Outstanding | 44.34 M | |||
| Shares Owned By Insiders | 49.15 % | |||
| Shares Owned By Institutions | 21.74 % | |||
| Price To Book | 2.86 X | |||
| Price To Sales | 4.73 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Elbit Stock
When determining whether Elbit Systems is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Elbit Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Elbit Systems Stock. Highlighted below are key reports to facilitate an investment decision about Elbit Systems Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elbit Systems. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Elbit Stock refer to our How to Trade Elbit Stock guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.